Clever Culture Systems Limited has released a press release.
Update on MRSA Analysis Module US FDA Submission
Filed with ASX ·
6ix hasn’t read this filing yet.
Clever Culture Systems Limited on 6ix
Earlier from Clever Culture Systems
- $1.5M Draw Down on South Australian Government Loan
- South Australian Government Agree to Extend Loan Facility
- Presentation at NWR Virtual Small Cap Conference
- US FDA 510(k) Submission for MRSA Analysis Module
- VRE Analysis Module - Clinical Study Commenced
Later from Clever Culture Systems
- First Sale of APAS Independence in United States
- Results of Evaluation of APAS Independence by Johns Hopkins
- Lbt teams with global clinical diagnostics company
- Trading Halt
- $8M private placement & launch of spp
Follow Clever Culture Systems into a list and get an email when it puts out news.
Follow Clever Culture Systems